E. Liu

Treatment with peginterferon plus ribavirin vs. interferon plus ribavirin for 48 weeks in Chinese patients with chronic hepatitis C

Enqi Liu, Y. Chu, A. Waqar, 2009, International journal of clinical practice.

Potentially effective drugs for the treatment of COVID-19 in children: a systematic review

Y. Chen, Z. Wang, S. Zhao, 2021, medRxiv.

Treatment of nasopharyngeal carcinoma with human leukocyte interferon.

T. Merigan, J. Connors, W. Andiman, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment with peginterferon versus interferon in Chinese patients with chronic hepatitis C

Y. Li, K. Wei, Y. Wang, 2010, European Journal of Clinical Microbiology & Infectious Diseases.

Peginterferon plus Chinese herbal therapy is associated with a higher virological response than only peginterferon therapy in chronic hepatitis C

Y. Wang, Y. Li, L. Bai, 2014, European Journal of Clinical Microbiology & Infectious Diseases.

Peginterferon vs. interferon in the treatment of different HCV genotype infections in HIV patients

Sihai Zhao, Enqi Liu, Y. Chu, 2008, European Journal of Clinical Microbiology & Infectious Diseases.